1,327
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Botulinum Neurotoxin a for Chronic Migraine Headaches: Does it Work and How?

&
Pages 377-380 | Published online: 11 Dec 2014

References

  • Aurora SK , DodickDW , TurkelCCet al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial . Cephalalgia30 ( 7 ), 793 – 803 ( 2010 ).
  • Diener HC , DodickDW , AuroraSKet al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial . Cephalalgia30 ( 7 ), 804 – 814 ( 2010 ).
  • Silberstein SD , BlumenfeldAM , CadyRKet al. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline . J. Neurol. Sci.331 ( 1–2 ), 48 – 56 ( 2013 ).
  • Jackson JL , KuriyamaA , HayashinoY . Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis . JAMA307 ( 16 ), 1736 – 1745 ( 2012 ).
  • Peña E . Treatment with botulinum toxin: an update . World J. Neurol.3 ( 3 ), 29 – 41 ( 2013 ).
  • Jakubowski M , McallisterPJ , BajwaZH , WardTN , SmithP , BursteinR . Exploding vs. imploding headache in migraine prophylaxis with botulinum toxin A . Pain125 , 286 – 295 ( 2006 ).
  • Lionetto L , NegroA , PalmisaniSet al. Emerging treatment for chronic migraine and refractory chronic migraine . Expert Opin. Emerg. Drugs17 ( 3 ), 393 – 406 ( 2012 ).
  • Tighe AP , SchiavoG . Botulinum neurotoxins: mechanism of action . Toxicon67 , 87 – 93 ( 2013 ).
  • Simpson L . The life history of a botulinum toxin molecule . Toxicon68 , 40 – 59 ( 2013 ).
  • Durham PL , CadyR . Insights into the mechanism of onabotulinumtoxinA in chronic migraine . Headache51 ( 10 ), 1573 – 1577 ( 2011 ).
  • Matak I , LackovicZ . Botulinum toxin A, brain and pain . Prog. Neurobiol. ( 2014 ) ( In Press ).
  • Arezzo JC . Possible mechanisms for the effects of botulinum toxin on pain . Clin. J. Pain18 ( 6 Suppl. ), S125 – S132 ( 2002 ).
  • Burstein R , ZhangX , LevyD , AokiKR , BrinMF . Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains . Cephalalgia ( 2014 ) ( In Press ).
  • Gazerani P , AuS , DongX , KumarU , Arendt-NielsenL , CairnsBE . Botulinum neurotoxin type A (BoNTA) decreases the mechanical sensitivity of nociceptors and inhibits neurogenic vasodilation in a craniofacial muscle targeted for migraine prophylaxis . Pain151 ( 3 ), 606 – 616 ( 2010 ).
  • Cairns BE , DongX , MannMKet al. Systemic administration of monosodium glutamate elevates intramuscular glutamate levels and sensitizes rat masseter muscle afferent fibers . Pain132 ( 1–2 ), 33 – 41 ( 2007 ).
  • Schueler M , MesslingerK , DuxM , NeuhuberWL , De ColR . Extracranial projections of meningeal afferents and their impact on meningeal nociception and headache . Pain154 ( 9 ), 1622 – 1631 ( 2013 ).
  • Bittencourt Da Silva L , KulasD , KarshenasAet al. Time course analysis of the effects of botulinum neurotoxin type A on pain and vasomotor responses evoked by glutamate injection into human temporalis muscles . Toxins (Basel)6 ( 2 ), 592 – 607 ( 2014 ).
  • Bittencourt Da Silva L , KarshenasA , BachFW , RasmussenS , Arendt-NielsenL , GazeraniP . Blockade of glutamate release by botulinum neurotoxin type A in humans: a dermal microdialysis study . Pain Res. Manag.19 ( 3 ), 126 – 132 ( 2014 ).
  • Blumenfeld A , AshkenaziA , NapchanUet al. Expert consensus recommendations for the performance of peripheral nerve blocks for headaches – a narrative review . Headache53 ( 3 ), 437 – 446 ( 2013 ).
  • Mustafa G , AndersonEM , Bokrand-DonatelliY , NeubertJK , CaudleRM . Anti-nociceptive effect of a conjugate of substance P and light chain of botulinum neurotoxin type A . Pain154 ( 11 ), 2547 – 2553 ( 2013 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.